UK markets closed

Kura Oncology, Inc. (KURA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
17.53-0.15 (-0.85%)
At close: 04:00PM EDT
17.53 +0.00 (+0.00%)
After hours: 04:15PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
37,318
51,802
90,672
325,493
Other short-term investments
386,639
386,183
427,288
307,827
Total cash
423,957
437,985
517,960
633,320
Other current assets
8,524
8,441
4,329
3,972
Total current assets
432,481
446,426
522,289
637,292
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
11,304
7,985
9,090
8,641
Accumulated depreciation
-2,452
-1,603
-844
-286
Net property, plant and equipment
8,852
6,382
8,246
8,355
Other long-term assets
7,602
3,498
3,516
1,565
Total non-current assets
16,454
9,880
11,762
9,920
Total assets
448,935
456,306
534,051
647,212
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
-
-
-
3,000
Accounts payable
2,300
1,533
3,236
2,753
Accrued liabilities
18,304
9,906
9,033
11,166
Total current liabilities
35,263
24,057
22,455
26,024
Non-current liabilities
Long-term debt
9,332
9,158
-
4,250
Other long-term liabilities
705
265
375
395
Total non-current liabilities
16,399
11,971
4,987
10,283
Total liabilities
51,662
36,028
27,442
36,307
Stockholders' equity
Common stock
7
7
7
7
Retained earnings
-721,439
-568,808
-432,968
-302,502
Accumulated other comprehensive income
-1,271
-8,032
-1,789
46
Total stockholders' equity
397,273
420,278
506,609
610,905
Total liabilities and stockholders' equity
448,935
456,306
534,051
647,212